Fierce Pharma August 12, 2022
Sunday, the U.S. Senate passed the landmark drug pricing bill. While the pharmaceutical industry favors the bill’s Medicare out-of-pocket cap for patients, the industry has also put up a major fight against Medicare pricing negotiations, in fact deeming them “price controls.” The bill’s passage marked a loss for the industry, but analysts aren’t sure how much the legislation will actually cut...